
Long COVID (LC), a post-COVID-19 syndrome, refers to symptoms persisting 12 weeks after COVID-19 infection. This study aims to test the feasibility and estimate the efficacy of the heart rate variability biofeedback (HRV-B) technique via a standardised slow diaphragmatic breathing programme in individuals with LC. The study has received ethical approval from Health Research Authority (HRA) Leicester South Research Ethics Committee (21/EM/0271). Dissemination plans include academic and lay publications.
Like
Save
Share